Immediate Impact
44 standout
Citing Papers
Mucosal immune response in biology, disease prevention and treatment
2025 Standout
Therapeutic effect of bosentan on 2, 4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis mouse model
2025 Standout
Works of Hiroshi Komazaki being referenced
Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate‐to‐severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long‐term studies*
2021
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
2020 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hiroshi Komazaki | 292 | 103 | 22 | 217 | 9 | 360 | |
| Lena Hagströmer | 255 | 63 | 27 | 114 | 13 | 340 | |
| Koichi Mitsuishi | 266 | 99 | 51 | 146 | 8 | 403 | |
| Sadaf Kasraie | 287 | 80 | 46 | 143 | 8 | 373 | |
| Sonja Grundmann | 261 | 48 | 12 | 138 | 16 | 393 | |
| Étienne Saint‐Cyr Proulx | 311 | 105 | 34 | 208 | 15 | 382 | |
| Lauren Becker | 286 | 164 | 13 | 200 | 7 | 365 | |
| Nick Othlinghaus | 233 | 73 | 25 | 121 | 10 | 352 | |
| Sho Hanakawa | 203 | 98 | 25 | 124 | 10 | 353 | |
| Girish C. Mohan | 213 | 64 | 20 | 103 | 13 | 336 | |
| U. Darsow | 215 | 118 | 11 | 223 | 8 | 375 |
All Works
Login with ORCID to disown or claim papers
Loading papers...